The estimated Net Worth of Mahesh V. Patel is at least $1.39 Million dollars as of 25 May 2023. Mahesh Patel owns over 8,706 units of Lipocine Inc stock worth over $421,079 and over the last 11 years he sold LPCN stock worth over $0. In addition, he makes $966,397 as Chairman of the Board, President, and Chief Executive Officer at Lipocine Inc.
Sign up
Mahesh Patel LPCN stock SEC Form 4 insiders trading
Mahesh has made over 21 trades of the Lipocine Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he bought 8,706 units of LPCN stock worth $43,791 on 25 May 2023.
The largest trade he's ever made was exercising 267,978 units of Lipocine Inc stock on 4 December 2020 worth over $1,050,474. On average, Mahesh trades about 28,623 units every 82 days since 2013. As of 25 May 2023 he still owns at least 107,418 units of Lipocine Inc stock.
You can see the complete history of Mahesh Patel stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mahesh Patel biography
Dr. Mahesh V. Patel, Ph.D., is Chairman of the Board, President, Chief Executive Officer of Lipocine Inc. He has served as Company's President and Chief Executive Officer since 1997 and as a member of Company's Board of Directors since 1997. Dr. Patel has more than 25 years of experience in strategic planning, technology assessment / development, technical management and product research and development in the area of drug discovery support, drug delivery and product line extensions. Prior to co-founding Lipocine in 1997, he led drug delivery research and development at Pharmacia and Upjohn. Dr. Patel received a B.Pharm from Karnataka University in India, a M.S. in Physical Pharmacy at the University of Cincinnati and a Ph.D. in Pharmaceutics from the University of Utah.
What is the salary of Mahesh Patel?
As the Chairman of the Board, President, and Chief Executive Officer of Lipocine Inc, the total compensation of Mahesh Patel at Lipocine Inc is $966,397. There are no executives at Lipocine Inc getting paid more.
How old is Mahesh Patel?
Mahesh Patel is 57, he's been the Chairman of the Board, President, and Chief Executive Officer of Lipocine Inc since 2014. There are 5 older and 7 younger executives at Lipocine Inc. The oldest executive at Lipocine Inc is Dr. Mahesh V. Patel Ph.D., 64, who is the Co-Founder, Interim Principal Financial Officer, Chairman, Pres & CEO.
What's Mahesh Patel's mailing address?
Mahesh's mailing address filed with the SEC is 675 ARAPEEN DR SUITE 202, , SALT LAKE CITY, UT, 84108.
Insiders trading at Lipocine Inc
Over the last 11 years, insiders at Lipocine Inc have traded over $9,045 worth of Lipocine Inc stock and bought 890,945 units worth $696,169 . The most active insiders traders include Mahesh V. Patel, John W. Higuchi, and Morgan R Brown. On average, Lipocine Inc executives and independent directors trade stock every 72 days with the average trade being worth of $148,846. The most recent stock trade was executed by Mahesh V. Patel on 25 May 2023, trading 8,706 units of LPCN stock currently worth $43,791.
What does Lipocine Inc do?
lipocine inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products. the company develops drugs based on hydroance, a drug delivery technology. it primarily focuses on developing oral versions of several hormones for use in men and women health. the company’s lipid-based technology platform offers non-invasive delivery solutions for small polar organics and macromolecules. it also offers custom drugs for pharmaceutical/biotechnology companies. lipocine inc. was founded in 1997 and is headquartered in salt lake city, utah.
What does Lipocine Inc's logo look like?
Complete history of Mahesh Patel stock trades at Lipocine Inc
Lipocine Inc executives and stock owners
Lipocine Inc executives and other stock owners filed with the SEC include:
-
Mahesh Patel,
Chairman of the Board, President, Chief Executive Officer -
Dr. Mahesh V. Patel Ph.D.,
Co-Founder, Interim Principal Financial Officer, Chairman, Pres & CEO -
Dr. Mahesh V. Patel,
Co-Founder, Chairman, Pres & CEO -
Morgan R. Brown CPA, CPA, M.B.A., MBA,
Corp. Sec. -
Morgan R. Brown CPA, M.B.A., CPA, MBA,
Exec. VP, CFO, Principal Accounting Officer & Corp. Sec. -
Morgan Brown,
Chief Financial Officer, Executive Vice President -
Nachiappan Chidambaram Ph.D.,
VP of Product Devel. -
John Higuchi,
Non-Executive Director -
Richard Ono,
Director -
Jeffrey Fink,
Director -
Stephen Hill,
Lead Independent Director -
Krista Fogarty,
Principal Accounting Officer & Corp. Controller -
Dr. Anthony DelConte M.D., M. D.,
Chief Medical Director -
Logan Morse,
VP of Sales, Marketing & Operations -
Jyrki Mattila,
Chief Business Officer -
Gregory Brooks Bass,
EVP and Chief Commercial Offic -
Srinivasan Venkateshwaran,
CTO and VP RandD -
Gerald T Simmons,
VP Corp Business Development -
Robert K. Merrell,
VP Finance -
Jill M. Jene,
Director -
Spyros Papapetropoulos,
Director -
Krista Fogarty,
Principal Accounting Officer -
George Nomikos,
Chief Medical Officer